Clinical Trial Update: A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and efficacy of ALPHAGAN P and LUMIGAN in patients previously treated with latanoprost for glaucoma and ocular hypertension; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• ALPHAGAN P (BRIMONIDINE TARTRATE)
• Lumigan (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2013-12-04